During the past decade, The Provincial Polyclinical Hospital in Torun conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Provincial Polyclinical Hospital in Torun" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Provincial Polyclinical Hospital in Torun" are "Heart Failure" (3 trials) and "Carcinoma, Non-Small-Cell Lung" (1 trials). Many other conditions were trialed in "The Provincial Polyclinical Hospital in Torun" in a lesser frequency.

Most popular intervention types in "The Provincial Polyclinical Hospital in Torun" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (3 trials), "Placebo" (3 trials), "Avastin" (1 trials) and "BI 695502" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Provincial Polyclinical Hospital in Torun" are 4 trials for "All" genders.

Currently, there are NaN active trials in "The Provincial Polyclinical Hospital in Torun". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The Provincial Polyclinical Hospital in Torun, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Provincial Polyclinical Hospital in Torun, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".